Simplify Logo

Full-Time

Associate Scientist II

Bioanalytical Chemistry

Posted on 10/23/2024

Vor Bio

Vor Bio

51-200 employees

Develops targeted therapies for blood cancers

Biotechnology
Healthcare

Junior, Mid

Cambridge, MA, USA

Generous transportation stipend offered.

Category
Lab & Research
Life Sciences
Required Skills
Data Analysis
Requirements
  • BS Coursework in Biochemistry or Biotechnology
  • 2+ years of analytical chemistry/biochemistry lab-based experience
  • Ability to work collaboratively in a team environment
  • Ability to consistently deliver exceptional results with impeccable attention to detail
  • Self-driven and motivated to excel
  • Ability to pivot in a fast-paced industry
  • Excellent problem-solving and communication skills
  • Creative, analytical and action-oriented mindset
  • Training in basic lab safety/chemical safety and various sample prep techniques
  • Track record of intellectually challenging oneself to enhance scientific capabilities
  • MS Coursework and/or co-op/internship experience in Analytical Biochemistry is preferred
  • 1+ years of experience with HPLC/ Chromatography methods development/optimization is preferred
  • 1+ years of experience designing and set-up of complex study designs; eg. Stability study
Responsibilities
  • Execute HPLC-based or other bioanalytical assays independently following established protocols - involving data acquisition, mobile phase/buffer preparation, instrument maintenance, troubleshooting, data analysis and report generation
  • Methodically test various conditions for new assay development and optimization
  • Maintain a detailed and updated ELN record of experiments conducted
  • Analyze and visualize experiment data
  • Collaborate with other groups/teams to perform in-process testing of materials and complete reporting workflows for those data in a timely manner
  • Write SOPs and update SOPs of existing assays in established non-GXP or GXP workflows as needed
  • Work cross-functionally to learn new platforms/assays that can be used to characterize raw materials
  • Perform literature searches to inform experiment design
  • Present study designs and results to internal and external stakeholders communicating in an effective manner to drive decision-making among stakeholders
  • Support and maintain critical starting material inventory, distributing critical starting materials as needed for studies and maintaining updated records of material distribution

Vor Biopharma focuses on developing treatments for blood cancers, particularly Acute Myeloid Leukemia (AML). Their approach is designed to protect healthy cells while specifically targeting and eliminating cancerous cells. This method aims to improve the effectiveness of blood cancer treatments. Vor Biopharma serves patients with blood cancers, their caregivers, and medical professionals in hospitals and oncology centers. What sets Vor Biopharma apart from its competitors is its commitment to extensive research and development of novel therapies, supported by a team with significant experience in the biopharmaceutical field. The company generates revenue through partnerships with other pharmaceutical companies and licensing agreements, with the goal of commercializing their therapies after obtaining regulatory approval.

Company Stage

IPO

Total Funding

$267.8M

Headquarters

Cambridge, Massachusetts

Founded

2015

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

3%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful transplantation of the first AML patient with Vor Bio’s investigational Trem-cel (VOR33) demonstrates promising clinical progress.
  • The recent $115.8 million funding round strengthens Vor Bio’s financial position, enabling further R&D and potential market expansion.
  • Strategic partnerships, such as the licensing agreement with Editas Medicine, enhance Vor Bio’s capabilities in gene editing and broaden its therapeutic pipeline.

What critics are saying

  • The highly specialized and competitive nature of the biopharmaceutical market requires continuous innovation and significant investment in R&D.
  • Regulatory hurdles and the lengthy approval process for new therapies can delay commercialization and revenue generation.

What makes Vor Bio unique

  • Vor Bio's unique approach of protecting healthy cells while targeting cancerous ones sets it apart in the competitive biopharmaceutical landscape.
  • The company's focus on Acute Myeloid Leukemia (AML) and its proprietary platform for gene-edited hematopoietic stem cell therapies provide a specialized niche.
  • Founded by a Pulitzer Prize-winning author and supported by a team of world-class leaders, Vor Bio leverages exceptional expertise and credibility in the biopharma sector.

Help us improve and share your feedback! Did you find this helpful?